Saturday 17 October 2026
Export AVTR’s income statement to Excel — free account
Avantor, Inc.
AVTR Healthcare Medical Instruments & Supplies
Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 33.3%, free cash flow grew 12.7% and total debt fell 12.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
16.42
0.33
+2.05%
Follow AVTR
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 7 | 5 | 6 | 5 | 6 | 4 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 312.78 | 49.00 | 20.55 | 47.40 | 20.07 | 0.00 |
P/S ratio |
0.00 | 0.00 | 0.00 | 1.21 | 2.54 | 3.37 | 1.83 | 2.21 | 2.11 | 1.19 |
Altman Z-Score |
— | — | — | 1.49 | 2.33 | 2.44 | 2.00 | 2.16 | 2.52 | 1.55 |
Altman Z″-Score (non-manufacturers) |
1.08 | — | 0.49 | 1.30 | 1.49 | 1.52 | 1.93 | 1.91 | 2.29 | 1.86 |
P/FCF ratio |
8.54 | 8.54 | 8.54 | 24.08 | 18.69 | 29.54 | 19.40 | 21.24 | 20.69 | 15.76 |
P/Operating CF |
25.67 | 25.67 | 25.67 | 83.70 | 53.02 | 82.67 | 67.02 | 61.09 | 82.63 | 51.08 |
Beneish M-Score |
— | — | — | (2.52) | (2.76) | (2.47) | (2.53) | (2.70) | (2.58) | (2.91) |
P/B ratio |
0.00 | 0.00 | 0.00 | 4.99 | 9.71 | 7.79 | 2.84 | 2.93 | 2.40 | 1.40 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | 2.02 | 3.26 | 4.28 | 2.62 | 2.96 | 2.67 | 1.74 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 12.41 | 18.51 | 23.11 | 12.69 | 18.57 | 12.06 | 65.97 |
EV/Operating CF |
31.45 | 31.45 | 31.45 | 34.50 | 22.40 | 33.14 | 23.35 | 23.73 | 21.54 | 18.24 |
EV/FCF |
38.45 | 38.45 | 38.45 | 40.38 | 23.99 | 37.51 | 27.73 | 28.53 | 26.18 | 22.99 |
Quick Ratio |
1.11 | 0.96 | 1.02 | 1.09 | 1.13 | 1.05 | 0.96 | 0.95 | 0.65 | 1.04 |
Current Ratio |
2.15 | 1.66 | 1.73 | 1.88 | 1.80 | 1.71 | 1.60 | 1.61 | 1.07 | 1.78 |
Net Debt/EBITDA |
12.58 | (69.68) | 7.84 | 5.01 | 4.09 | 4.91 | 3.81 | 4.74 | 2.53 | 20.76 |
Debt/Assets |
114.08% | 0.00% | 69.86% | 52.35% | 49.40% | 50.54% | 46.70% | 42.68% | 33.48% | 33.46% |
Debt/Equity |
(3.46) | 0.00 | (2.27) | 2.08 | 1.83 | 1.67 | 1.29 | 1.05 | 0.68 | 0.71 |
Asset Turnover |
0.12 | 2.20 | 1.06 | 0.61 | 0.65 | 0.62 | 0.55 | 0.53 | 0.54 | 0.55 |
Operating CF/Net income |
(1.74) | 1.49 | (0.56) | (1.06) | 17.88 | 1.88 | 1.27 | 2.71 | 1.18 | (1.18) |
Capex/Depreciation |
0.00 | (0.23) | (0.08) | (0.12) | (0.15) | (0.28) | (0.32) | (0.35) | (0.36) | (0.31) |
Interest Coverage |
0.69 | (1.05) | 0.79 | 1.25 | 2.30 | 4.47 | 4.25 | 2.45 | 4.96 | (1.45) |
| 2.80% | 7.53% | 12.57% | 42.07% | 3.32% | 20.89% | 16.46% | 6.35% | 12.69% | (9.20%) | |
| (0.73%) | (19.84%) | (6.45%) | (3.40%) | 0.53% | 4.27% | 4.84% | 2.43% | 5.67% | (4.44%) | |
ROIC |
0.00% | (1.90%) | 7.01% | 4.67% | 6.07% | 5.57% | 6.56% | 4.13% | 6.95% | (1.68%) |
Return on Tangible Assets |
(11.67%) | (8.08%) | (25.42%) | (22.28%) | 3.38% | 29.33% | 38.37% | 19.55% | 83.98% | (28.83%) |
Average Days of Receivables |
46.48 | 256.03 | 57.96 | 59.75 | 63.56 | 60.39 | 59.20 | 60.26 | 55.66 | 59.86 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
40.96% | 36.05% | 23.96% | 22.66% | 21.49% | 20.72% | 19.60% | 21.62% | 24.19% | 24.35% |
Intangible Assets out of Total Assets |
0.55 | 0.00 | 0.74 | 0.72 | 0.70 | 0.75 | 0.73 | 0.73 | 0.73 | 0.69 |
Share Based Compensation of Revenue |
0.00% | 3.86% | 0.31% | 1.12% | 0.69% | 0.69% | 0.61% | 0.58% | 0.69% | 0.71% |
Graham Net Nets |
0.99 | 0.99 | 0.99 | (0.73) | (0.31) | (0.29) | (0.43) | (0.35) | (0.28) | (0.48) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 2.42 | 10.23 | 13.15 | 9.16 | 14.39 | 0.00 |
Earnings Yield |
(10.55%) | (10.55%) | (10.55%) | (5.05%) | 0.32% | 2.04% | 4.87% | 2.11% | 4.98% | (6.81%) |
Free Cash Flow Yield |
11.71% | 11.71% | 11.71% | 4.15% | 5.35% | 3.39% | 5.15% | 4.71% | 4.83% | 6.35% |
Revenue per Share |
1.29 | 8.26 | 44.19 | 15.06 | 11.09 | 12.51 | 11.54 | 10.31 | 9.98 | 9.63 |
Operating CF per Share |
0.14 | (1.11) | 1.51 | 0.88 | 1.61 | 1.61 | 1.30 | 1.29 | 1.24 | 0.92 |
Capex per Share |
0.00 | (0.17) | (0.28) | (0.13) | (0.11) | (0.19) | (0.20) | (0.22) | (0.22) | (0.19) |
Free Cash Flow per Share |
0.14 | (1.28) | 1.23 | 0.75 | 1.51 | 1.43 | 1.09 | 1.07 | 1.02 | 0.73 |
Cash per Share |
0.12 | 1.22 | 1.39 | 0.47 | 0.50 | 0.51 | 0.57 | 0.39 | 0.39 | 0.54 |
Shareholders Equity per Share |
(0.70) | 0.00 | (23.00) | 6.14 | 4.64 | 7.11 | 7.46 | 7.77 | 8.77 | 8.18 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.70) | 0.00 | (23.00) | 6.14 | 4.64 | 7.11 | 7.46 | 7.77 | 8.77 | 8.18 |
Free Cash Flow |
72.90 | (192.70) | 162.80 | 302.40 | 868.20 | 842.50 | 710.20 | 723.60 | 692.00 | 495.00 |
Working Capital |
156.00 | 730.00 | 803.40 | 947.00 | 988.20 | 1,026.40 | 999.10 | 904.60 | 139.10 | 1,072.30 |
Capital Expenditures |
(29.90) | (25.20) | (37.70) | (51.60) | (61.60) | (111.10) | (133.40) | (146.40) | (148.80) | (128.80) |
Net Current Asset Value |
(1,354.00) | 1,834.00 | (11,063.70) | (5,289.60) | (5,001.30) | (7,223.00) | (5,951.00) | (5,335.20) | (4,011.20) | (3,778.50) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 22.13 | 29.47 | 32.51 | 17.43 | 29.64 | 16.70 | 0.00 |
Capex to Sales |
0.00 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 13.20 | 22.95 | 25.60 | 12.19 | 22.07 | 13.20 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.30 | 0.17 | 0.75 | 0.78 | 0.76 | 0.56 | 0.58 | 0.56 | 0.59 | 0.55 |
Cash ROIC |
7.41% | (2.64%) | 4.01% | 3.89% | 11.05% | 7.31% | 6.17% | 6.55% | 6.74% | 5.01% |
Accounts Receivable Turnover |
1.44 | 2.59 | 6.49 | 6.29 | 6.08 | 6.33 | 6.16 | 5.88 | 6.21 | 6.21 |
Accounts Payable Turnover |
1.26 | 2.76 | 7.36 | 7.37 | 6.96 | 6.81 | 6.49 | 6.65 | 6.99 | 6.28 |
Inventory Turnover |
0.91 | 1.99 | 5.92 | 5.96 | 5.95 | 6.06 | 5.50 | 5.29 | 5.78 | 5.70 |
Average Days of Payables |
47.10 | 242.86 | 50.30 | 49.63 | 57.45 | 56.44 | 56.37 | 49.63 | 53.71 | 61.35 |
Days of Inventory on Hand |
119.70 | 311.41 | 60.56 | 63.01 | 62.59 | 65.18 | 67.91 | 65.66 | 59.28 | 67.68 |
Average Receivables |
481.50 | 481.50 | 903.10 | 960.00 | 1,051.05 | 1,167.70 | 1,220.25 | 1,184.30 | 1,092.35 | 1,054.55 |
Average Payables |
295.00 | 295.00 | 549.70 | 558.80 | 619.55 | 717.00 | 756.65 | 692.05 | 644.35 | 702.25 |
Average Inventory |
408.50 | 408.50 | 683.05 | 691.15 | 725.40 | 805.80 | 892.75 | 870.80 | 779.80 | 774.85 |
Average Assets |
5,791.50 | 568.00 | 5,523.80 | 9,842.45 | 9,839.90 | 11,901.85 | 13,680.75 | 13,218.50 | 12,543.60 | 11,954.60 |
Average Common Equity |
(1,497.50) | (1,497.50) | (2,835.85) | (796.60) | 1,564.55 | 2,431.95 | 4,024.35 | 5,054.00 | 5,604.65 | 5,760.85 |
Columns are period end dates